Provoke Discussions. Face the Experts. Convince with Your Results.

Professional scientific talks on international and national congresses going into the depth of basic research, building a bridge in translational research or communicating the latest results from clinical data for our patients have been awarded in many cases. Provocative contexts and in depth discussions with an eye for relevant information have to be presented in a brief and concise manner to convince and leave a long-lasting impression on experts and sponsors for external funding.

Here you will find a selection of scientific talks on national and international congresses of the last years.

  • Quality of implantation of therapies for secondary prevention in patients with peripheral arterial disease in in- and outpatient care, Germany, 2017
  • How to really lose weight – a novel medical device to change eating behaviour, Germany, 2017
  • Superior therapeutic effect of intermittent vasodilator infusion therapy on walking distance among patients with peripheral arterial disease and intermittent claudication, Germany, 2017
  • Long-term weight maintenance after weight reduction with the trainer brackets in overweight and obesity. Germany, 2015
  • Beyond brilliant ideas – scientifically sound studies for the long-term success story of biotechnologic start-ups. Germany, 2014
  • Early and 12 months long-term results after transpopliteal angioplasty compared with antegrade angioplasty. DGA, Hamburg, Germany, 2014
  • Impaired endothelial regeneration through human parvovirus B19-infected circulating angiogenic cells in end-organ diesase. DGA, Hamburg, Germany, 2014.
  • Gene therapy / stem cell therapy in critical ischaemia: Update 2014. University Heidelberg, Germany, 2014
  • Therapeutic suppression of Parvovirus B19 replication with the thymidine analogon telbivudine improves clinical outcome in chronic myocarditis and reduces apoptosis in circulating angiogenic cells. DGK, Mannheim, Germany, 2013
  • Gender-specific differences in antiaggregation: what do we have to consider in cardiology? DGK, Mannheim, Germany, 2012

Presence with Stunning Topics. Ahead of Time.

  • Stem cell therapy in peripheral arterial disease (PAD) III / IV. University Bonn, Germany, 2010
  • Pre-transplant prognostic factors of clinical outcome after implantation of autologous bone marrow mononuclear cells in chronic limb ischaemia. DGK, Mannheim, Germany, 2010
  • Endothelial progenitor cells represent a novel target in parvovirus B19-associated endothelial dysfunction. Symposium Infection of the Endothelium, Dresden, Germany, 2009
  • Cardiac migration of mesenchymal stem cells in inflammatory cardiomyopathy. ESC Heart Failure, Nice, France, 2009

© 2018 MEDIACC GmbH